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ABSTRACT: The organization of the genome within interphase nuclei, and
how it interacts with nuclear structures is important for the regulation
of nuclear functions. Many of the studies researching the importance
of genome organization and nuclear structure are performed in young,
proliferating, and often transformed cells. These studies do not reveal
anything about the nucleus or genome in nonproliferating cells, which
may be relevant for the regulation of both proliferation and replicative
senescence. Here, we provide an overview of what is known about the
genome and nuclear structure in senescent cells. We review the evidence
that nuclear structures, such as the nuclear lamina, nucleoli, the nuclear
matrix, nuclear bodies (such as promyelocytic leukemia bodies), and nu-
clear morphology all become altered within growth-arrested or senescent
cells. Specific alterations to the genome in senescent cells, as compared to
young proliferating cells, are described, including aneuploidy, chromatin
modifications, chromosome positioning, relocation of heterochromatin,
and changes to telomeres.
KEYWORDS: senescence; chromosome positioning; nuclear architecture;
laminopathies; genome organization
INTRODUCTION
Cellular senescence is a state of viable growth arrest arrived at after repeated
passage in culture. For any cell strain, senescence is reached after a finite and
predictable number of population doublings. The process leading to senes-
cence arrest (termed replicative senescence) is characterized by the gradual
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accumulation of nondividing cells throughout the reproductive life span of the
culture.1 It has been suggested that the process of cellular senescence is linked
to the process of organismal aging, and indeed a number of studies have shown
that senescent cells accumulate within tissues with increasing chronological
age.2–4 Senescent cells display an altered phenotype compared with their pro-
liferative antecedents5,6 revealing a functional change in genome behavior. We
are interested in the changes in senescent cells and how this may be influenced
by alterations in genome organization.
The nucleus houses and protects the genome and further influences and
controls the function of the genome. For many decades, due to limited under-
standing of this organelle, it was termed the “black box” of the cell.7 However,
in the last few decades there have been many new advances in techniques,
such as microscopy and molecular biology, allowing us to understand more
and more about how the nucleus is organized and how it functions.
The nucleus is compartmentalized, comprising a number of nuclear struc-
tures and regions that manage restricted nuclear activities. The structural com-
ponents of the nucleus are intimately linked to the genome allowing signaling
and ultimately control of the genome function.8 These nuclear structures in-
clude the nuclear envelope, nucleoli, nuclear bodies, and the nuclear matrix
(FIG. 1). Misorganization or defects in nuclear structures and/or architecture
are associated with cancer and severe premature aging diseases, such as the
progeroid syndromes and laminopathies.9 Thus, it is important that we fully
understand how the nucleus and the genome functions in aged and senescent
cells.
FIGURE 1. A diagram displaying some of the components of an interphase nucleus,
that is, the nuclear lamina, nucleoli, the nuclear matrix, PML bodies, and chromosome
territories.
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The genome is organized within the nucleus as whole chromosomes. There
are many influences on the genome to regulate gene expression, including epi-
genetic modifications, such as methylation and acetylation, which alter chro-
matin behavior.10–12 Furthermore, the actual location of the chromatin, how it
associates with nuclear structures and even other regions of the genome are
also factors in controlling transcriptional capabilities of a genomic region.11,13
Thus, intricate properties of chromosomes, including organization, spatial lo-
cation, interaction with nuclear architecture as well as various epigenetic phe-
nomena, work together to ensure that transcription is correctly regulated.14,15
CHANGES IN THE MORPHOLOGY
OF SENESCENT CELLS
It is clear from simple microscopical observations that the morphology of
cells change during cellular aging. Indeed, senescent fibroblasts become much
larger and lose their elongated spindle-like qualities, becoming much more
amorphous in shape and no longer bipolar.16–18
Senescent cells also have larger nuclei. This is demonstrated here by a study,
where human dermal fibroblasts (NB1 cell strain19) were fixed at early (<10%
life span completed) or late (>95% life span completed) passage, stained, im-
aged and their nuclear area measured digitally. FIGURE 2 shows a frequency
distribution plot of nuclear area of cells in early and late passage cultures. There
is a shift in both the mean and median nuclear area between the two groups
(mean = 255 m2 early passage, 293 m2 late passage; median = 240 m2
early passage, 285 m2 late passage) revealing that cellular aging is charac-
terized by a shift in nuclear area toward larger nuclei.
FIGURE 2. Frequency distribution plot of nuclear area size categories from human
dermal fibroblasts in early or late passage cultures.
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CHANGES IN CHROMATIN IN
SENESCENT CELLS
Efficient transcription of a genome requires a combination of compact pack-
aging of the chromatin within the constraints of the nucleus and accessibility of
the region of the genome that is to be transcribed.20 The genome is packaged
as less compact, more open, euchromatin, and more condensed heterochro-
matin consisting of facultative and constitutive heterochromatin. Euchromatin
has commonly been associated with transcriptionally active regions of the
genome, although there are inactive genes found within open chromatin and
actively transcribed genes within compact chromatin.21
It appears that there is spatial relocation of silenced genes to regions of
heterochromatin within nuclei but it is not yet clear how spatial relocalization
to repressed regions of the nucleus is specifically involved in gene silencing.22
Heterochromatin formation has been closely studied in senescent cells by
Narita et al.23 This study revealed the formation of senescence-associated het-
erochromatic foci (SAHF). These are regions that contain the heterochromatic
protein HP1, heterochromatic markers, and high mobility group A proteins.
These heterochromatic structures may have a role in transcriptional repression
of proliferation-associated genes. The SAHF are enriched in a transcription-
ally repressive variant of H2A, macroH2A.24,25 Histones may be an important
facilitator of genome behavior in senescent cells since an earlier study revealed
that in senescent cells there is a decrease in the synthesis of histone H1, leading
to less H1 in aged cells.26
Recent evidence has associated chronological age with an increase in het-
erochromatinization of regions of the genome within human lymphocytes.
Lezhava demonstrates a higher percentage of condensed chromatin in inter-
phase nuclei of cells derived from older people (80–93 years) as compared
to cells derived from younger people (25–52 years).27 Further, the transcrip-
tional activity of the old cells with higher levels of heterochromatinization
was observed to have decreased as compared to younger or middle-aged
cells.
Thus, there appears to be a common link between increased heterochroma-
tinization in senescence and organismal aging suggesting that the two processes
are related.
DNA methylation of genomic regions at cytosine residues is another epige-
netic phenomenon involved in gene silencing and thus in the regulation of gene
transcription. Methylation is also thought to be an important feature during the
transition of the cell from a proliferating state to a senescent state.28,29 Indeed,
hypermethylation may cause heterochromatinization and thus would result in
gene silencing.30
It is not yet clear how methylation plays a role in aging, but this epige-
netic factor does seem to be an important target for future studies.28 However,
cells derived from the premature aging disease Werner Syndrome, may be
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an interesting model to use in the study of senescence-like DNA methylation
patterns.31
TELOMERES AND THEIR ROLE
IN SENESCENT CELLS
Telomeres are DNA sequences found at the ends of chromosomes. They
bind nucleoproteins, protect chromosome ends from degradation and end-
to-end fusions, and mediate the process of chromosomal replication.32 Each
telomere comprises kilobases of hexameric repeats and a 3′overhang of 100–
400 nucleotides at their ends,33,34 forming a T-loop structure that is stabilized
by telomeric proteins. The combination of DNA with proteins bound to it forms
the protective telomere cap.
Telomeres may act as a “replicational” clock that keeps track of the number
of cell divisions a cell has undergone, as with each cycle of DNA replication,
a small part of the overhanging DNA that forms the ends of the telomeres
is lost.35,36 Thus, cells undergo divisions until they reach a state termed as
“senescence erode” which is characterized by shortening of the telomere to half
of its original size.35,37 Thus, telomere shortening or attrition has been accepted
as one of the major hallmarks of aging cells.35 However, recent insights have
proposed that telomere length per se is not as important as the capped state
of telomeres,38 and that uncapped telomeres lead to a protective double-strand
break repair response inducing cells to enter the senescent state.39
CHANGES IN NUCLEAR ARCHITECTURE
IN SENESCENT CELLS
Nucleoli
The nucleolus is the site of synthesis, processing, and maturation of preri-
bosomal particles. However, recent evidence has demonstrated roles for the
nucleolus in aging, proliferation control, and stress responses.40 Nevertheless,
the nucleolus remains the paradigm for structure–function relationships in the
nucleus.41
The nucleolus undergoes several changes as a cell ages; some of which have
implications on its function. An initial visual comparison between the nucleoli
of senescent and presenescent cells is that senescent cells have a single but
larger nucleolus whereas presenescent cells show a higher number of small
nucleoli.42
There are a number of proteins, which are involved in cellular senescence
that reside in the nucleoli. Proteins, such as p14 ARF and nucleophosmin,
are present in the nucleolus as well as the nucleoplasm, and are involved in
releasing and facilitating p53 stability.43,44
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Thus, the nucleolus is not only affected by the process of cellular senescence,
but may play a role in the process of replicative senescence.
Nuclear Matrix
The nuclear matrix/nucleoskeleton is a filamentous network of protein,
DNA, and RNA that remains in nuclei when cells are treated with high salt
and nucleases.45,46 This structure, made up of 10 nm filaments, anatomizes
through the nucleoplasm and is thought to provide structural support to the
nucleus. It is also involved in defining the nuclear size and shape.11
The nuclear matrix serves as a skeleton for the nucleus and is the structure
that supports DNA replication, transcription, and repair,11 RNA splicing and
transport,46 maintaining the strict compartmentalization of the nucleus,47,48
and providing an architectural scaffolding for higher-order chromatin packag-
ing.49 Some components that associate or constitute the nuclear matrix include
nuclear lamins.50–52
Two-dimensional electrophoretic analysis of the synthesis of nuclear matrix
proteins from presenescent and senescent human fibroblasts revealed several
changes in nuclear matrix composition between the two cell types.53 In par-
ticular, the level of synthesis of an unidentified 47-kDa peptide was cell cycle
regulated in presenescent cells and synthesized at constitutively high levels in
senescent cells.
The nuclear matrix appears to anchor the genome through telomeres,54–56
centromeres,57,58 and matrix attachment regions.59 Interestingly, it has been
shown that the nuclear matrix could not bind the TRF1 protein found at telom-
eres in primary fibroblasts but could in immortal fibroblasts.60 Hence alter-
ations to binding of nuclear matrix and telomeres could affect the cells pro-
gression into the cell cycle as well as the entry of the cell into senescence.55,61
Telomere anchoring is very important for the repair of DNA breaks occurring
in these regions, thus, any disruption to this binding can result in inability of
the cell to repair DNA damage and thereby would cause the cell to undergo
apoptosis or senescence.
Bickmore and colleagues demonstrated that the gene-rich chromosome HSA
19 was always tethered to the nuclear matrix when nuclear matrices were
prepared from human lymphoblasts and fibroblasts without the use of DNA
nuclease; while the gene-poor chromosome HSA 18 appeared to be dispersed
away from the residual nucleus in the DNA halo.62
Nuclear Lamina
The nucleus is separated from the cytoplasm by a nuclear envelope made up
of inner and outer nuclear membranes, nuclear pore complexes, and the lamina.
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The inner nuclear membrane binds a set of integral and membrane-associated
proteins and protein complexes that can bind to chromatin.63 Underlying the
inner nuclear membrane is a network of lamin polymers that form a meshwork
of filaments called the nuclear lamina,64 which maintains nuclear integrity and
tethers specific regions of the genome to the nuclear periphery.8
The major components of the nuclear lamina are the type-V intermediate
filament A- and B-type lamin proteins,65 which interact with the nuclear mem-
brane, integral membrane proteins, chromatin binding proteins, and soluble
proteins.66,67 Nuclear lamins are vital for chromatin organization,68–70 DNA
replication,71 RNA polymerase II-dependent gene expression,72 and bridging
the gap between the nucleoskeleton and the cytoskeleton.73
B-type lamins appear to be essential for survival in vivo since mice engi-
neered with mutations in lamin B are able to complete development but die
shortly after birth.74 Fibroblast cultures derived from embryos harboring the
mutations display a variety of aberrant cellular phenotypes including prema-
ture senescence and display grossly misshapen nuclei. Overexpression of lamin
B1 in humans causes autosomal dominant leukodystrophy.75
On the other hand, loss of A-type lamins in vivo does not seem to affect
development and mice lacking A-type lamins survive beyond birth. However,
3 weeks after birth the mice developed muscular dystrophies, loss of white fat,
thymic atrophy, growth retardation, and a disruption to spermatogenesis.69,76
Mutations in A-type lamins can result in a wide range of diseases termed
“laminopathies” (for review see Ref.77). Among these diseases are two seg-
mental progeroid syndromes, Hutchinson Gilford Progeria Syndrome (HGPS)
and Atypical Werner Syndrome (AWS). In vitro studies have revealed that
perturbations to the A-type lamina have profound effects upon both nuclear
structure and function including premature cellular senescence and increased
rates of apoptosis.19
During the process of cellular aging in normal fibroblasts, there is an increase
in the fraction of cells displaying gross abnormalities in nuclear shape. This
accumulation appears to be exaggerated in laminopathy cells and may be linked
with premature senescence19 (Mehta I.S., Figgitt M., Meaburn K.J., Kill I.R.,
Bridger J.M., unpublished).
Indeed, there is some evidence that accumulation of abnormal nuclei occurs
with human aging in vivo.78
Promyelocytic Leukemia Bodies
Promyelocytic leukemia (PML) bodies are known to have an influence on
cell cycle progression and to an extent on cellular senescence.79
PML bodies are spherical bodies found scattered throughout the nucleo-
plasm attached to the nuclear matrix,80 outside chromosome territories.81 The
structure and stability of these nuclear bodies seem to be highly dependent on
the integrity of the chromatin they associate with.82 These nuclear structures
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FIGURE 3. A model demonstrating the repositioning of chromosomes when human
dermal fibroblasts become senescent. The positions of chromosomes change from a gene-
density correlated radial position to a size correlated radial position.
play vital roles in DNA replication and repair, cell cycle control, apoptosis,83,84
and in gene transcription.85–87 PML bodies also associate with very specific
parts of the genome; they have been found to be clustered near gene-rich and
transcriptionally active regions of the genome,88,89 but may also be involved
in gene repression.90
Their association with the genome is very dynamic and changes as the
cell progresses through the cell cycle.89 PML bodies are also involved in the
process of cellular senescence either via p5391,92 or via hypophosphorylated
pRB pathways.93
CHANGES IN CHROMOSOME BEHAVIOR
IN SENESCENT CELLS
Chromosomes in interphase nuclei occupy their own individual chromosome
territories,94–97 which are irregularly shaped and largely immobile at submicron
level.98−100
Current models of nuclear organization support the idea that chromosomes
in the interphase nucleus are arranged nonrandomly, in a radial organization,
with each chromosome occupying a discrete area of the nucleus.13,62,101–104
Analyses from a number of laboratories demonstrate that radial chromoso-
mal positioning in proliferating interphase nuclei is correlated with gene den-
sity.62,101,105–107 This theory suggests that chromosomes are organized radially
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with gene-rich chromosomes grouped in the nuclear interior while gene-poor
chromosomes are located at the nuclear periphery. Interestingly, as cells enter a
nonproliferating state, either senescence or quiescence, chromosomes become
relocalized within nuclei, but still maintain a radial distribution.102 We have
found that chromosomes are positioned in senescent cells according to a size-
related distribution (Mehta I.S., Figgitt M., Meaburn K.J., Kill I.R., Bridger
J.M., unpublished). This indicates that a number of small chromosomes move
from the nuclear periphery to the nuclear interior and other larger chromosomes
move to the nuclear periphery from a more internal nuclear location (see FIG. 3).
Furthermore, the position of specific chromosomes in proliferating nuclei of
laminopathy cells is altered and resembles that of normal senescent cells.108
How this repositioning of chromosomes affects gene expression or function is
as yet unknown. However, given that young laminopathy cells behave in some
regards as aged normal cells, this implies that A-type lamins are involved in
normal cellular senescence.77
Another similar phenomenon concerning the genome behavior in senes-
cent cells18,109,110 and laminopathy cells111 is aneuploidy. This could of course
severely affect cellular functions in normal senescent cells and in young pro-
liferating cells of laminopathy patients.
In summary, the genome and the nuclear architecture it interacts with un-
dergo dramatic changes as cells enter senescence, leading to major alterations
in genome function in senescent cells.
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